Description
Model-informed clinical pharmacokinetics consultation service providing real-time PK assessment and dose recommendations to achieve pre-defined goal exposure as part of routine clinical care or prospective concentration-control clinical trials
Market positioning
Specialized clinical service provider in pediatric pharmacokinetics
Target audience
Clinicians, pediatricians, oncologists, transplant specialists, and healthcare providers needing specialized dosing guidance
Use cases
Model-informed clinical pharmacokinetics consultation service providing real-time PK assessment and dose recommendations to achieve pre-defined goal exposure as part of routine clinical care or prospective concentration-control clinical trials
Company information
Company size
<UNKNOWN>
Revenue
<UNKNOWN>
Scale
Specialized clinical service
Number of users
<UNKNOWN>
Features
Pricing
Rating
Pros and cons
Based on: (AI summary)
Pros
- Real-time clinical decision support
- Broad drug coverage across therapeutic areas
- Integration with clinical workflows
- Evidence-based recommendations
- Support for both routine care and research
Cons
- Limited to Cincinnati Children's Hospital
- Requires specialized pharmacokinetics expertise
- May have limited availability based on staffing
- Dependent on timely laboratory results
Feature Comparison
Top features across 5 competitors (most common first)
| Feature | PrecisePK T… | Simcyp Pedi… | Clinical Ph… | Model-Infor… | Physiologic… |
|---|---|---|---|---|---|
| immunosuppressives | |||||
| biologics | |||||
| Acute Kidney Injury (AKI) prediction tool | |||||
| Bayesian-guided precision dosing | |||||
| Model-Informed Precision Dosing (MIPD) | |||||
| Multi-language support (English | |||||
| Spanish | |||||
| Chinese | |||||
| Thai | |||||
| Korean) | |||||
| Multiple drug modules | |||||
| Real-time monitoring and analytics | |||||
| SOC2 and ISO/IEC 27001 compliance | |||||
| Vancomycin AUC dosing calculator | |||||
| Advanced PBPK modeling and simulation | |||||
| Pediatric population modeling | |||||
| Diverse population analysis | |||||
| Drug behavior prediction | |||||
| Advanced simulation capabilities | |||||
| Regulatory-ready modeling |